| Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma JK Sa, N Chang, HW Lee, HJ Cho, M Ceccarelli, L Cerulo, J Yin, SS Kim, ... Genome biology 21, 1-17, 2020 | 82 | 2020 |
| cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors B Min, J Jin, H Kim, NG Her, C Park, D Kim, J Yang, J Hwang, E Kim, ... ACS omega 5 (40), 25798-25809, 2020 | 10 | 2020 |
| Semi-automated cell panning for efficient isolation of fgfr3-targeting antibody B Min, M Yoo, H Kim, M Cho, DH Nam, Y Yoon International Journal of Molecular Sciences 22 (12), 6240, 2021 | 3 | 2021 |
| Preclinical characterization of AMB302/GQ1011, a first-in-class FGFR3 antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor against diverse FGFR3 overexpression or … B Min, S Lee, W Jung, L Wang, Y Sun, H Kim, NG Her, PH Song, G Qin, ... Cancer Research 84 (6_Supplement), 3123-3123, 2024 | | 2024 |
| AMB302/GR1017, an antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor shows therapeutic potency in orthotopic glioblastoma PDX and bladder cancer models with FGFR3 … B Min, L Shi, HJ Kim, S Kim, B Fan, C Lv, Y Sun, NG Her, P Song, G Qin, ... Cancer Research 83 (7_Supplement), 2634-2634, 2023 | | 2023 |
